- Home
- UHT vs FTRE Comparison
UHT vs FTRE Comparison
Compare UHT & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHT
- FTRE
- Stock Information
- Founded
- UHT 1986
- FTRE 1996
- Country
- UHT United States
- FTRE United States
- Employees
- UHT N/A
- FTRE N/A
- Industry
- UHT Real Estate Investment Trusts
- FTRE Medical Specialities
- Sector
- UHT Real Estate
- FTRE Health Care
- Exchange
- UHT Nasdaq
- FTRE Nasdaq
- Market Cap
- UHT 540.7M
- FTRE 469.0M
- IPO Year
- UHT N/A
- FTRE N/A
- Fundamental
- Price
- UHT $38.64
- FTRE $4.78
- Analyst Decision
- UHT
- FTRE Hold
- Analyst Count
- UHT 0
- FTRE 11
- Target Price
- UHT N/A
- FTRE $17.10
- AVG Volume (30 Days)
- UHT 46.3K
- FTRE 3.1M
- Earning Date
- UHT 04-28-2025
- FTRE 05-12-2025
- Dividend Yield
- UHT 7.60%
- FTRE N/A
- EPS Growth
- UHT 15.38
- FTRE N/A
- EPS
- UHT 1.35
- FTRE N/A
- Revenue
- UHT $99,725,000.00
- FTRE $2,685,600,000.00
- Revenue This Year
- UHT N/A
- FTRE N/A
- Revenue Next Year
- UHT N/A
- FTRE $3.32
- P/E Ratio
- UHT $28.72
- FTRE N/A
- Revenue Growth
- UHT 1.03
- FTRE N/A
- 52 Week Low
- UHT $34.56
- FTRE $4.77
- 52 Week High
- UHT $47.30
- FTRE $37.24
- Technical
- Relative Strength Index (RSI)
- UHT 47.71
- FTRE 33.51
- Support Level
- UHT $38.60
- FTRE $5.40
- Resistance Level
- UHT $39.57
- FTRE $7.99
- Average True Range (ATR)
- UHT 0.75
- FTRE 0.64
- MACD
- UHT 0.08
- FTRE 0.05
- Stochastic Oscillator
- UHT 55.07
- FTRE 8.29
About UHT Universal Health Realty Income Trust
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.